Free Trial

iHuman Inc. Sponsored ADR (NYSE:IH) Short Interest Up 311.4% in March

iHuman logo with Consumer Discretionary background
Image from MarketBeat Media, LLC.

Key Points

  • Short interest in iHuman (NYSE:IH) rose 311.4% in March to 1,876 shares as of March 13 (from 456 on Feb. 26), but remains small relative to volume with a days-to-cover of 0.4 days.
  • Weiss Ratings downgraded iHuman from a "hold (c-)" to a "sell (d+)", and MarketBeat reports the stock's average analyst rating is "Sell."
  • Hedge fund Acadian Asset Management bought 15,067 shares (~$32,000) in Q1, leaving institutional ownership at roughly 4.92%.
  • Five stocks to consider instead of iHuman.

iHuman Inc. Sponsored ADR (NYSE:IH - Get Free Report) saw a large increase in short interest in March. As of March 13th, there was short interest totaling 1,876 shares, an increase of 311.4% from the February 26th total of 456 shares. Currently, 0.0% of the company's stock are short sold. Based on an average trading volume of 5,346 shares, the days-to-cover ratio is presently 0.4 days. Based on an average trading volume of 5,346 shares, the days-to-cover ratio is presently 0.4 days. Currently, 0.0% of the company's stock are short sold.

Analysts Set New Price Targets

Separately, Weiss Ratings lowered shares of iHuman from a "hold (c-)" rating to a "sell (d+)" rating in a research note on Monday, January 26th. One equities research analyst has rated the stock with a Sell rating, According to MarketBeat, iHuman presently has an average rating of "Sell".

View Our Latest Stock Report on IH

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in iHuman stock. Acadian Asset Management LLC acquired a new position in iHuman Inc. Sponsored ADR (NYSE:IH - Free Report) in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The firm acquired 15,067 shares of the company's stock, valued at approximately $32,000. 4.92% of the stock is currently owned by institutional investors and hedge funds.

iHuman Stock Up 5.2%

NYSE:IH opened at $1.79 on Wednesday. The stock has a market cap of $91.42 million, a price-to-earnings ratio of 6.39 and a beta of 0.05. The company's 50 day moving average price is $1.86 and its 200-day moving average price is $2.35. iHuman has a 52 week low of $1.67 and a 52 week high of $3.60.

iHuman (NYSE:IH - Get Free Report) last announced its quarterly earnings data on Monday, December 29th. The company reported $0.06 earnings per share for the quarter. iHuman had a net margin of 12.55% and a return on equity of 11.05%. The company had revenue of $28.90 million during the quarter.

About iHuman

(Get Free Report)

iHuman Inc provides intellectual development products to individual users, kindergartens, and distributors in the People's Republic of China. The company offers interactive and self-directed learning apps, including iHuman Chinese, iHuman ABC, iHuman Pinyin, iHuman Magic Thinking, iHuman Books, iHuman Stories, iHuman Reading, iHumanpedia, iHuman Kids Workout, iHuman Coding, iHuman Fun Idioms, iHuman Little Artists, iHuman Writing, iHuman Fantastic Friends, and iHuman Readers; bekids Coding, bekids Coloring, bekids Reading, bekids Puzzle, bekids Academy, and Gogo Town; and Aha World, an open-ended interactive app that nurtures a desire for discovery.

Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in iHuman Right Now?

Before you consider iHuman, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and iHuman wasn't on the list.

While iHuman currently has a Sell rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Stocks to Own in 2026 Cover

Click the link to see MarketBeat's list of ten stocks that are set to soar in 2026, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines